Back to mobile site

Goldman Sachs Reiterates Buy Rating on Eli Lilly (LLY)

December 18, 2025 10:06 AM EST Send to a Friend
Goldman Sachs analyst Asad Haider reiterated a Buy rating and $1,145.00 price target on Eli Lilly (NYSE: LLY).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login